The global quantitative pathology imaging market is poised for remarkable growth, with projections soaring to USD 9.5 billion by 2032, up from USD 2.77 billion in 2022. This substantial leap reflects a robust Compound Annual Growth Rate (CAGR) of 11.9% anticipated over the forecast period.
Advancements in QPI technologies are driving this exponential expansion, revolutionizing the field of pathology with unprecedented precision and detailed insights. These cutting-edge technologies are reshaping diagnostic practices, enhancing accuracy, and profoundly influencing treatment decisions.
Get Sample Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5041
A key driver of this growth is the advent of digital pathology, which involves the utilization of digital scanners to convert tissue samples into high-resolution digital images. These digital images can then be analyzed using QPI software to extract quantitative information. Digital pathology is gaining traction due to its numerous advantages over traditional microscopy, including enhanced image quality, seamless image sharing capabilities, and the ability to perform intricate quantitative analysis.
Furthermore, the escalating demand for personalized medicine is propelling the QPI market forward. Personalized medicine entails tailoring treatment strategies to individual patients based on their distinct genetic and molecular profiles. QPI plays a pivotal role in this paradigm shift by enabling the identification of biomarkers that guide personalized treatment decisions, thereby optimizing patient outcomes.
The key takeaways from the quantitative pathology imaging market report are as follows:
- The global quantitative pathology imaging market is expected to grow at a CAGR of 11.9% during the forecast period.
- The market is driven by the increasing prevalence of cancer and other chronic diseases, the rising demand for personalized medicine, and the growing adoption of digital pathology.
- Oncology is the largest segment of the quantitative pathology imaging market, accounting for over 50% of the market share in 2022.
- North America is the largest regional market for quantitative pathology imaging, accounting for over 40% of the global market share in 2022.
Checkout Now to Access Targeted Data: https://www.futuremarketinsights.com/checkout/5041
Key Companies Profiled:
- Leica Biosystems (Danaher)
- Hamamatsu Photonics, Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- Mikroscan Technologies
- Inspirata, Inc.
- 3DHISTECH Ltd.
- Visiopharm A/S
- Huron Technologies International, Inc.
- ContextVision AB
Key Segments In The Quantitative Pathology Imaging Market:
By Product:
- Instruments
- Software
- Services
By Application:
- Drug Discovery and Development
- Academic Research
- Disease Diagnosis
By End-User:
- Hospitals
- Clinics
- Pathology Diagnostic Laboratories
- Research Institutes
By Region:
- North America
- Latin America
- Europe
- Asia
- Middle East and Africa
A Comprehensive Full Report: https://www.futuremarketinsights.com/reports/quantitative-pathology-imaging-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube